A blog about what is new (and old) in the world of active implantable medical devices

Monthly Archives: July 2019

Berlin Heals First-In-Man Pilot Trial of its C-MIC Device

Posted on by Posted in Berlin Heals, Cardiac Stimulation (other), Heart Failure (CHF)
Berlin Heals C-MIC implantable device

Image Credit: Berlin Heals

Berlin Heals GmbH – a private Switzerland-based company with an R&D branch in Berlin, Germany – started a FIH-Pilot-Trial of its C-MIC device at AKH Vienna and at the Hospital Center Dedinje in Belgrade.

The C-MIC is an implantable electroceutical device intended to readjust the disturbed myocardial electrical gradient that, according to Berlin Heals, occurs in heart failure patients.

Dr. Peter Göttel from Berlin Heals told me that as of today, 4 patients have been implanted between the two sites.

Berlin Heals website: http://berlinheals.de/

Berlin Heals announcement: http://berlinheals.de/pilot-study-initiated/

Berlin Heals C-MIC

C-MIC Device. Image Credit: Berlin Heals

Boston Scientific Reports Weak CRM and Neuromodulation Growth

Posted on by Posted in AIMD Business, Boston Scientific, Cardiac Pacing, Cardioversion/Defibrillation, Neural Stimulation

Boston Scientific Logo

Boston Scientific’s Q2 2019 results are out, and they show very weak growth for Cardiac Rhythm Management.

According to the announcement, Q2 2019 CRM sales were $498M, compared to $494M for the same period last year, which constitutes a 0.6% increase on reported basis.

Neuromodulation grew from $202M last year to $204M, or 1.0% on reported basis.

Purdue University Develops Implantable Naloxone Injector

Posted on by Posted in Anaphilaxix, Drug Delivery, Opioid Overdose
Prototype implantable emergency drug injector by H Lee and his team at Purdue University.

Prototype implantable emergency drug injector by H Lee and his team at Purdue University.
Image Credit: Purdue University

Dr. Hyowon “Hugh” Lee, an assistant professor of biomedical engineering and his team at Purdue University have been developing an interesting implantable drug delivery system. Unlike traditional pumps, this device is meant as a one-time injector for life-saving drugs such as naloxone (opioid antidote) or epinephrine (treatment for anaphylactic reaction).

Purdue researchers are developing a wearable device that would automatically deliver an antidote upon detecting opioid overdose, buying time for emergency services to arrive. (Purdue University image/Jongcheon Lim)

The implantable “A2D2” capsule contains the drug in a capsule that is sealed with a phase-change material. When heated, this material melts and allows the capsule’s payload to be delivered to the body. Continue reading→